Zhenghua Su
825, Zhangheng Road
Pudong, China
Pudong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Novel regulation mechanism of histone methyltransferase SMYD5 in rheumatoid arthritis.
Journal: Cellular & molecular biology letters
Published: September 19, 2024
Proteogenomic Landscape of Breast Ductal Carcinoma Reveals Tumor Progression Characteristics and Therapeutic Targets.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 28, 2024
The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy.
Journal: Cell death & disease
Published: January 11, 2024
Functional role of Ash2l in oxLDL induced endothelial dysfunction and atherosclerosis.
Journal: Cellular and molecular life sciences : CMLS
Published: September 11, 2023
Poly (ADP-ribose) polymerases 16 triggers pathological cardiac hypertrophy via activating IRE1α-sXBP1-GATA4 pathway.
Journal: Cellular and molecular life sciences : CMLS
Published: February 28, 2023
Histone methyltransferase Smyd2 drives vascular aging by its enhancer-dependent activity.
Journal: Aging
Published: July 28, 2022
Histone methyltransferase Smyd2 drives adipogenesis via regulating STAT3 phosphorylation.
Journal: Cell death & disease
Published: June 07, 2022
Correction: The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis.
Correction: The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis.
Journal: Cell death & disease
Published: February 15, 2022
Inhibition of the cardiac fibroblast-enriched histone methyltransferase Dot1L prevents cardiac fibrosis and cardiac dysfunction.
Journal: Cell & bioscience
Published: January 06, 2022
Histone methyltransferase Smyd2 contributes to blood-brain barrier breakdown in stroke.
Journal: Clinical and translational medicine
Published: October 18, 2021
The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis.
Journal: Cell death & disease
Published: June 20, 2021
SMYD2-mediated TRAF2 methylation promotes the NF-κB signaling pathways in inflammatory diseases.
Journal: Clinical and translational medicine
Published: May 11, 2021
Last Updated: 09/26/2026